Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/2070
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPonsford, Jennie-
dc.contributor.authorCarmichael, Jai-
dc.contributor.authorHicks, Amelia-
dc.contributor.otherSpitz, Gershon-
dc.contributor.otherGould, Kate Rachel-
dc.date.accessioned2022-04-01T03:05:01Z-
dc.date.available2022-04-01T03:05:01Z-
dc.date.issued2021-11-
dc.identifier.citationNeurosci Biobehav Rev . 2021 Nov;130:107-124en_US
dc.identifier.issn1873 7528en_US
dc.identifier.issn0149 7634en_US
dc.identifier.urihttp://hdl.handle.net/11434/2070-
dc.description.abstractThe field of genomics is the principal avenue in the ongoing development of precision/personalised medicine for a variety of health conditions. However, relating genes to outcomes is notoriously complex, especially when considering that other variables can change, or moderate, gene-outcome associations. Here, we comprehensively discuss moderation of gene-outcome associations in the context of traumatic brain injury (TBI), a common, chronically debilitating, and costly neurological condition that is under complex polygenic influence. We focus our narrative review on single nucleotide polymorphisms (SNPs) of three of the most studied genes (apolipoprotein E, brain-derived neurotrophic factor, and catechol-O-methyltransferase) and on three demographic variables believed to moderate associations between these SNPs and TBI outcomes (age, biological sex, and ethnicity). We speculate on the mechanisms which may underlie these moderating effects, drawing widely from biomolecular and behavioural research (n = 175 scientific reports) within the TBI population (n = 72) and other neurological, healthy, ageing, and psychiatric populations (n = 103). We conclude with methodological recommendations for improved exploration of moderators in future genetics research in TBI and other populations.en_US
dc.publisherElsevieren_US
dc.subjectAPOEen_US
dc.subjectAntagonistic Pleiotropyen_US
dc.subjectApolipoprotein Een_US
dc.subjectBDNFen_US
dc.subjectBrain-Derived Neurotrophic Factoren_US
dc.subjectCOMTen_US
dc.subjectCatechol-O-methyltransferaseen_US
dc.subjectDopamineen_US
dc.subjectEstrogenen_US
dc.subjectEthnicityen_US
dc.subjectGeneticsen_US
dc.subjectPrecision Medicineen_US
dc.subjectSexen_US
dc.subjectTraumatic Brain Injuryen_US
dc.subjectTBIen_US
dc.subjectMonash Epworth Rehabilitation Research Centre, Richmond, Victoria, Australiaen_US
dc.subjectRehabilitation Medicine, Epworth HealthCare, Richmond, Victoria, Australiaen_US
dc.subjectRehabilitation, Mental Health and Chronic Pain Clinical Instituteen_US
dc.subjectNeurosciences Clinical Institute, Epworth HealthCare, Victoria, Australiaen_US
dc.titleModerators of gene-outcome associations following traumatic brain injury.en_US
dc.typeJournal Articleen_US
dc.identifier.doi10.1016/j.neubiorev.2021.08.015en_US
dc.identifier.journaltitleNeuroscience & Biobehavioral Reviewsen_US
dc.description.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/34411558en_US
dc.description.affiliatesurner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Australiaen_US
dc.type.studyortrialNarrative Reviewsen_US
dc.type.contenttypeTexten_US
Appears in Collections:Neurosciences
Rehabilitation

Files in This Item:
There are no files associated with this item.


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.